TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression

被引:80
作者
Chu, HW
Jeyaseelan, S
Rino, JG
Voelker, DR
Wexler, RB
Campbell, K
Harbeck, RJ
Martin, RJ
机构
[1] Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA
[2] Univ Colorado, Hlth Sci Ctr, Denver, CO 80206 USA
关键词
D O I
10.4049/jimmunol.174.9.5713
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Excessive airway mucin production contributes to airway obstruction in lung diseases such as asthma and chronic obstructive pulmonary disease. Respiratory infections, such as atypical bacterium Mycoplasma pneumoniae (Mp), have been proposed to worsen asthma and chronic obstructive pulmonary disease in part through increasing mucin. However, the molecular mechanisms involved in infection-induced airway mucin overexpression remain to be determined. TLRs have been recently shown to be a critical component in host innate immune response to infections. TLR2 signaling has been proposed to be involved in inflammatory cell activation by mycoplasma-derived lipoproteins. In this study, we show that TLR2 signaling is critical in Mp-induced airway mucin expression in mice and human lung epithelial cells. Respiratory Mp infection in BALB/c mice activated TLR2 signaling and increased airway mucin. A TLR2-neutralizing Ab significantly reduced mucin expression in Mp-infected BALB/c mice. Furthermore, Mp-induced airway mucin was abolished in TLR2 gene-deficient C57BL/6 mice. Additionally, Mp was shown to increase human lung A549 epithelial cell mucin expression, which was inhibited by the overexpression of a human TLR2 dominant-negative mutant. These results clearly demonstrate that respiratory Mp infection increases airway mucin expression, which is dependent on the activation of TLR2 signaling. The Journal of Immunology, 2005.
引用
收藏
页码:5713 / 5719
页数:7
相关论文
共 24 条
  • [1] Human surfactant protein D (SP-D) binds Mycoplasma pneumoniae by high affinity interactions with lipids
    Chiba, H
    Pattanajitvilai, S
    Evans, AJ
    Harbeck, RJ
    Voelker, DR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (23) : 20379 - 20385
  • [2] Chu H. W., 2002, Clinical and Experimental Allergy, V32, P1558, DOI 10.1046/j.1365-2222.2002.01477.x
  • [3] Inhaled fluticasone propionate reduces concentration of Mycoplasma pneumoniae, inflammation, and bronchial hyperresponsiveness in lungs of mice
    Chu, HW
    Campbell, JA
    Rino, JG
    Harbeck, RJ
    Martin, RJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (06) : 1119 - 1127
  • [5] Remodeling of the airway epithelium in asthma
    Fahy, JV
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (10) : S46 - S51
  • [6] GIL JC, 1993, ANN ALLERGY, V70, P23
  • [7] Counteracting interactions between lipopolysaccharide molecules with differential activation of toll-like receptors
    Hajishengallis, G
    Martin, M
    Schifferle, RE
    Genco, RJ
    [J]. INFECTION AND IMMUNITY, 2002, 70 (12) : 6658 - 6664
  • [8] Transforming growth factor-β-Smad signaling pathway cooperates with NF-κB to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription
    Jono, H
    Shuto, T
    Xu, HD
    Kai, H
    Lim, DJ
    Gum, JR
    Kim, YS
    Yamaoka, S
    Feng, XH
    Li, JD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (47) : 45547 - 45557
  • [9] Kim Suil, 2004, Treat Respir Med, V3, P147, DOI 10.2165/00151829-200403030-00003
  • [10] Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma
    Kraft, M
    Cassell, GH
    Henson, JE
    Watson, H
    Williamson, J
    Marmion, BP
    Gaydos, CA
    Martin, RJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (03) : 998 - 1001